- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/10 - 1,2,4-TriazolesHydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 249/10
Total number of patents in this class: 214
10-year publication summary
|
19
|
15
|
10
|
16
|
9
|
9
|
12
|
8
|
6
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 362 |
20 |
| Eonhf, Inc. | 45 |
10 |
| BASF SE | 21303 |
7 |
| Bayer Pharma AG | 1014 |
7 |
| Theravance, Inc. | 61 |
6 |
| Corteva Agriscience LLC | 2648 |
6 |
| Synta Pharmaceuticals Corp. | 145 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 852 |
5 |
| Tokyo Ohka Kogyo Co., Ltd. | 1562 |
4 |
| Novartis AG | 10262 |
3 |
| F. Hoffmann-La Roche AG | 7837 |
3 |
| Vertex Pharmaceuticals Incorporated | 1582 |
3 |
| Bionomics Limited | 85 |
3 |
| Canopy Growth Corporation | 212 |
3 |
| FMC Corporation | 807 |
3 |
| KalVista Pharmaceuticals Limited | 93 |
3 |
| SK Biopharmaceuticals Co., Ltd. | 277 |
3 |
| The Regents of the University of California | 20745 |
2 |
| Bayer AG | 3501 |
2 |
| The General Hospital Corporation | 4870 |
2 |
| Other owners | 114 |